Fostering directly observed treatment in tuberculosis: a program manager's perspective.

Area of Science:

• Public Health
• Infectious Disease Control
• Global Health

Background:

• India accounts for 26% of the global tuberculosis (TB) cases, indicating challenges in achieving Millennium Development Goal 6.
• The Revised National TB Control Program (RNTCP) is the primary strategy for TB prevention and control in India.
• Directly Observed Treatment, Short-course chemotherapy (DOTS) is recognized as a priority for effective TB control.

Purpose of the Study:

• To highlight the importance of Directly Observed Treatment (DOT) within the RNTCP framework.
• To emphasize the role of DOT in ensuring treatment adherence and improving TB control outcomes in India.
• To advocate for evidence-based strategies addressing barriers to universal DOT administration.

Main Methods:

• The study reviews the RNTCP strategy and its emphasis on DOT.
• It discusses the role of DOT providers in patient support and drug consumption.
• The RNTCP's treatment adherence scheme (public-private partnership) is mentioned as an initiative.

Main Results:

• Directly Observed Treatment (DOT) is integral to the DOTS strategy, ensuring patient adherence.
• DOT providers play a vital role in supporting patients throughout their treatment course.
• The RNTCP's initiatives aim for universal access to TB care and improved treatment adherence.

Conclusions:

• DOT in the RNTCP ensures long-term adherence to TB treatment, including correct medication and dosage.
• This adherence is indispensable for improving program outcome indicators and patient quality of life.
• An integrated strategy promoting universal DOT administration is recommended for enhanced TB control.